Dihydromonacolin L

CAS : 86827-77-2

Ref. 3D-LDA82777

Informations sur le produit

• Nom: Dihydromonacolin L
• Synonymes: 2H-Pyran-2-one, tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-, (4R,6R)-, 4a,5-Dihydromonacolin L, (4R,6R)-Tetrahydro-4-hydroxy-6-[2-[(1S,2S,4aR,6R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-2,6-dimethyl-1-naphthalenyl]ethyl]-2H-pyran-2-one

Description

Dihydromonacolin L is a kinase inhibitor that has shown promise in the treatment of cancer. It is derived from Chinese medicinal herbs and has been found to induce apoptosis, or programmed cell death, in cancer cells. Dihydromonacolin L has been shown to be effective against a variety of tumors, including leukemia, by inhibiting the cell cycle and inducing apoptosis. This compound is an attractive target for anticancer drug development due to its potent inhibitory activity against protein kinases. In recent studies, it has been found that Dihydromonacolin L can enhance the anticancer effects of nintedanib, another cancer drug. Overall, Dihydromonacolin L shows great potential as a new class of anticancer agents with promising therapeutic applications.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 306.4 g/mol
• Formule: C₁₉H₃₀O₃
• Degré de pureté: Min. 95%